Scientific Advisors

Dr.Kalimuthu Kalishwaralal working as a MK Bhan Young Researcher Fellow at Rajiv Gandhi Centre for Biotechnology, Kerala. He is the one of the top 2% scientists in the world published by stanford university (2020-2022). He has a keen interest in the fields of Nanotechnology, biotechnology, and molecular biology, with a particular focus on cancer biology research and developing novel therapies to combat cancer. Their primary research interests involve identifying molecular pathways and designing targeted therapies to specifically target cancer cells. One approach that intrigues the researcher involves utilizing peptides, obtained from phage display libraries, to deliver chemical or biological therapeutics molecules to cancer cells. He has completed postdoctoral research spanning four years at three renowned universities, including the University of Pittsburgh in the USA, Ariel University in Israel, and Konkuk University in South Korea.He has achieved a significant level of research success, as evidenced by their impressive publication citation count of 8461 and a respectable h-index of 34 as per the Google citation.

Dr. Sunil Kumar Tripathi is a Bioinformatician and his area of research interest includes Computational Medicinal Chemistry, Computational Biophysics and Molecular Modeling & Drug Design. Dr. Sunil Kumar Tripathi obtained his Ph.D. in Bioinformatics (2014) from the Department of Bioinformatics, Alagappa University, India. He Did his postdoctoral research in International esteemed institute and university that include Regional Center for Biotechnology, Faridabad, India, University of Duisburg Essen, Essen, Germany, University of Michigan, Ann Arbor, USA. His research focuses on molecular modeling techniques to investigate biomolecular systems with emphasis on conformational changes, protein-protein and protein-ligand interactions. He employs Cosolvent Mixed-solvent molecular dynamics (MixMD), classical MD simulations, enhanced sampling, free energy calculations and structure- and ligand-based drug design approaches for the design of small molecules as inhibitors of therapeutically important drug targets. Currently, he is working as senior researcher in Department of Chemistry, Georgia State University, Atlanta, USA. His work is to understand eukaryotic transcription initiation which begins with the gathering of the transcription preinitiation complex (PIC) onto promoter DNA with the help of transcription factor IID (TFIID), RNA polymerase II (Pol II) and the role of co-activator Mediator utilizing cryo-electron microscopy data, advanced computational modeling, and using emerging powerful tools of computational biology.

A computational chemist well versed in use of structure‑based design techniques like molecular docking, virtual screening, and pharmacophore modeling in drug discovery. Over 6 years of expertise in the use of molecular dynamics to study structure‑function relationship of macromolecules & leveraging the information to drive drug discovery. Over two years of experience in computational protein (antigens, antibody), peptide design and optimization using Rosetta.

Well versed in basic molecular biology techniques, protein expression, protein design and in‑vitro assay techniques. Indian Board certification in Pharmacy practice. Two years of experience in primary and secondary market research and scientific writing. Demonstrated team‑working and cross‑cultural skills.

Contributed to 10 peer‑reviewed research and articles as an author and co‑author; cited > 120 times.

Dr. Johson Retnaraj Samuel unravelling the mysteries of 'Regeneration and Stem Cell Biology' with the help of earthworms and Zebrafish as animal model systems. He discovered the characteristics of stem cells and regeneration-specific miRNA and mRNA. In addition to studies related to regeneration and stem cells, he has developed an alternate supply of FBS. He contributed 21 peer-reviewed research and review papers with a total impact factor of 65.